Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-08-10 16:09:10 ET · period of report 2026-08-07 · accession 0001839832-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 16:09 | 2026-08-07 | TMO | Holmes Joseph R. | VP, CAO | M - OptEx | $309.63 | +420 | 3,386 | +14% | +$130.0K |
| D | 2026-08-10 16:09 | 2026-08-07 | TMO | Holmes Joseph R. | VP, CAO | S - Sale+OE | $584.81 | -420 | 2,966 | -12% | -$245.6K |
| D | 2026-08-10 16:09 | 2026-08-07 | TMO | Holmes Joseph R. | VP, CAO | M - OptEx | $0.00 | -420 | 140 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-07 | M | A | 420 | $309.63 | 3,386.36 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-07 | S | D | 420 | $584.81 | 2,966.36 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-07 | M | D | 420 | $0.00 | 140 | D | $309.63 · — to 2027-02-25 | 420 Common Stock | (F1) The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. (F1) The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. |